CinCor Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2018-01-01
- Employees
- 15
- Market Cap
- -
- Website
- http://www.cincor.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)A Study of CIN-107 in Patients With Uncontrolled Hypertension
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- CinCor Pharma, Inc.
- Target Recruit Count
- 249
- Registration Number
- NCT05137002
- Locations
- 🇺🇸
CinCor Site 27, Saraland, Alabama, United States
🇺🇸CinCor Site 35, Tucson, Arizona, United States
🇺🇸CinCor Site 69, Encinitas, California, United States
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- CinCor Pharma, Inc.
- Target Recruit Count
- 275
- Registration Number
- NCT04519658
- Locations
- 🇺🇸
CinCor Site 16, Birmingham, Alabama, United States
🇺🇸CinCor Site 38, Birmingham, Alabama, United States
🇺🇸CinCor Site 61, Saraland, Alabama, United States
News
No news found